文献速递心境障碍

抑郁症代谢组学特征:230种代谢标志物的汇总分析

Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls.
PubMed 文献 · Biol Psychiatry · 2019-08-29

该研究汇总9个荷兰队列,纳入5283例抑郁症患者和10145名对照,使用质子核磁共振代谢组学平台检测230种代谢标志物,发现21种脂质、脂肪酸及低分子量代谢物与抑郁症显著相关,提示抑郁症存在独特的循环脂质代谢谱。

要点

  • 抑郁症与载脂蛋白B、极低密度脂蛋白胆固醇、甘油三酯等升高及高密度脂蛋白胆固醇降低相关。
  • 脂质组成分析显示抑郁症患者高密度脂蛋白颗粒减少、极低密度脂蛋白和甘油三酯颗粒增多。
  • 代谢关联在不同性别、年龄、体质指数分层及诊断与症状队列中基本一致。

核心结论

  • 大规模荟萃分析表明抑郁症与独特的循环脂质代谢物谱相关,可能为抑郁症及其心代谢共病的预防或治疗提供新途径。

研究设计与样本

  • 纳入9个荷兰队列,包括10145名对照和5283例抑郁症患者,抑郁症通过诊断访谈或问卷确定。
  • 采用质子核磁共振代谢组学平台检测230种代谢物指标:51种脂质、脂肪酸和低分子量代谢物,98种脂蛋白亚类的脂质组成和颗粒浓度指标,81种脂质和脂肪酸比值。
  • 对每个代谢物指标在队列内进行逻辑回归分析,调整性别、年龄、吸烟、空腹状态和调脂药物,随后进行随机效应荟萃分析。

主要发现

  • 51种脂质、脂肪酸和低分子量代谢物中,21种与抑郁症显著相关(错误发现率q < .05)。
  • 载脂蛋白B、极低密度脂蛋白胆固醇、甘油三酯、甘油二酯、总脂肪酸和单不饱和脂肪酸、脂肪酸链长度、糖蛋白乙酰基、酪氨酸和异亮氨酸水平较高与抑郁症风险增加相关。
  • 高密度脂蛋白胆固醇、乙酸和载脂蛋白A1水平较低与抑郁症风险增加相关。
  • 脂质组成指标分析证实抑郁症患者向高密度脂蛋白减少、极低密度脂蛋白和甘油三酯颗粒增多的方向转变。
  • 关联在不同性别、年龄和体质指数分层以及抑郁症诊断与症状队列间基本一致。

关键数值与推荐

  • 显著性标准为错误发现率q < .05。
  • 230种代谢物指标包括51种脂质、脂肪酸和低分子量代谢物,98种脂蛋白亚类指标,81种脂质和脂肪酸比值。

临床怎么用

  • 临床可关注抑郁症患者循环脂质代谢谱,尤其是载脂蛋白B、极低密度脂蛋白胆固醇、甘油三酯、高密度脂蛋白胆固醇和载脂蛋白A1等指标。
  • 对抑郁症患者进行心代谢风险评估时,可考虑脂质代谢异常与抑郁症的关联,以识别心代谢共病高风险个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Depression has been associated with metabolic alterations, which adversely impact cardiometabolic health. Here, a comprehensive set of metabolic markers, predominantly lipids, was compared between depressed and nondepressed persons. METHODS: Nine Dutch cohorts were included, comprising 10,145 control subjects and 5283 persons with depression, established with diagnostic interviews or questionnaires. A proton nuclear magnetic resonance metabolomics platform provided 230 metabolite measures: 51 lipids, fatty acids, and low-molecular-weight metabolites; 98 lipid composition and particle concentration measures of lipoprotein subclasses; and 81 lipid and fatty acids ratios. For each metabolite measure, logistic regression analyses adjusted for gender, age, smoking, fasting status, and lipid-modifying medication were performed within cohort, followed by random-effects meta-analyses. RESULTS: Of the 51 lipids, fatty acids, and low-molecular-weight metabolites, 21 were significantly related to depression (false discovery rate q < .05). Higher levels of apolipoprotein B, very-low-density lipoprotein cholesterol, triglycerides, diglycerides, total and monounsaturated fatty acids, fatty acid chain length, glycoprotein acetyls, tyrosine, and isoleucine and lower levels of high-density lipoprotein cholesterol, acetate, and apolipoprotein A1 were associated with increased odds of depression. Analyses of lipid composition indicators confirmed a shift toward less high-density lipoprotein and more very-low-density lipoprotein and triglyceride particles in depression. Associations appeared generally consistent across gender, age, and body mass index strata and across cohorts with depressive diagnoses versus symptoms. CONCLUSIONS: This large-scale meta-analysis indicates a clear distinctive profile of circulating lipid metabolites associated with depression, potentially opening new prevention or treatment avenues for depression and its associated cardiometabolic comorbidity.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Bot M, Milaneschi Y, Al-Shehri T, et al. Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls. Biol Psychiatry. 2019. PMID: 31635762. doi:10.1016/j.biopsych.2019.08.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。